Patents Assigned to Universite Henri Poincare Nancy I
  • Patent number: 8021836
    Abstract: The present invention concerns a method of diagnosing disease of bacterial or fungal origin in a subject, which method comprises the step of measuring the level of Strem-1 in a biological sample obtained from said subject.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: September 20, 2011
    Assignee: Université Henri Poincaré-Nancy I
    Inventors: Marie Nathalie Kolopp-Sarda, Marie-Christine Bene, Paola Panina, Pietro Di Lucia, Bruno Levy, Pierre-Edouard Bollaert, Gilbert Faure, Sebastien Gibot
  • Patent number: 8013116
    Abstract: A polypeptide comprising one or more sequences derived from CDR2 or CDR3 of a TREM-1 protein, characterized by the ability to treat, ameliorate, or lessen the symptoms of conditions including sepsis, septic shock or sepsis-like conditions and IBD.
    Type: Grant
    Filed: February 2, 2009
    Date of Patent: September 6, 2011
    Assignees: Universite Henri-Poincare-Nancy I, Novo Nordisk A/S
    Inventors: Gilbert Faure, Sebastien Gibot, Paola Panina, Nadia Passini
  • Publication number: 20100191095
    Abstract: A method for collecting and a device for sensing at least one electrophysiological signal, as well as to a system including at least one such device. The device for sensing at least one electrophysiological signal from a living subject subjected to at least one electromagnetic field, includes elements, such as electrodes, which are placed on the subject for the physical acquisition of at least one electrophysiological signal and at least elements for the pre-processing of the at least one sampled electrophysiological signal. The sensor device (1) is characterised in that it also includes additional elements (7, 8) for measuring or determining at least one characteristic of the electromagnetic environment at or close to the electrophysiological signal acquisition point(s) or zone(s) on the subject.
    Type: Application
    Filed: April 25, 2008
    Publication date: July 29, 2010
    Applicants: SCHILLER MEDICAL, UNIVERSITE HENRI POINCARE-NANCY I, UNIVERSITE DE STRASBOURG, CENTRE HOSPITALIER ET UNIVERSITAIRE DE NANCY
    Inventors: Jacques Felblinger, Michel Kraemer, Jean-Philippe Blonde, Roger Abacherli, Vincent Frick, Johann-Jakob Schmid
  • Patent number: 7718773
    Abstract: A protein includes or is formed by: (i) SEQ ID NO: 1; (ii) any sequence that is derived from sequence SEQ ID NO: 1, for example, by the substitution, removal or addition of one or more amino acids, on the condition that the derivative sequence binds to the phosphate; (iii) any sequence that is homologous to sequence SEQ ID NO: 1, preferably having a homology of at least approximately 80% with sequence SEQ ID NO: 1, on the condition that the homologous sequence binds to the phosphate; or (iv) any fragment of one of the aforementioned sequences on the condition that the fragment binds to the phosphate, such as any fragment comprising at least approximately 20 contiguous amino acids in sequence SEQ ID NO: 1.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: May 18, 2010
    Assignees: Centre National de le Recherche Scientifique, Universite Henri Poincare Nancy I
    Inventors: Eric Chabriere, Carlos Contreras-Martel, Juan Fontecilla-Camps